Total Funding
84
59
Total FundingSeries B raised
Growth Score 84 in past quarter
-6 pts
Heat Score 59 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
8870
Epikast provides technology-enabled commercial and clinical services for the biopharmaceutical industry.
- Vangelis Vergetis: Co-founder & CEOPast Role: Intelligencia AI, Co-Founder & CEO
About the Company
Epikast provides services and tools to support engagement between biopharmaceutical teams and key stakeholders such as patients, physicians, and healthcare professionals. It offers medically trained sales representatives, Medical Science Liaisons, reimbursement and market access specialists, and customized patient engagement support backed by data
and AI insights. Epikast integrates human expertise with technology to help clients navigate complex treatment workflows and improve communications across channels. Its services aim to align talent and tools with client objectives to support outreach, scientific exchange, and patient support programs. The company also emphasizes compliance and tailored deployment in its engagements.
Women Founded